Evaluation of a novel 18F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats

Circulation: Cardiovascular Imaging

Volumn 2, Issue 2, 2009, Pages 77-84

  Sherif, Hossam M ^a,c   Saraste, Antti ^a   Weidl, Eliane ^a   Weber, Axel W ^a   Higuchi, Takahiro ^a   Reder, Sybille ^a   Poethko, Thorsten ^a   Henriksen, Gjermund ^a   Casebier, David ^b   Robinson, Simon ^b   Wester, Hans Jürgen ^a   Nekolla, Stephan G ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b A Subsidiary of Lantheus Holdings   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

18F BMS747158 02; Cardiac PET; Myocardial infarction; Perfusion; TTC staining

Indexed keywords

BMS 74715802; BMS 74715802 F18; FLUORINE 18; TRACER; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; BMS 747158 02; BMS 747158-02; DIAGNOSTIC AGENT; FLUORINE; PYRIDAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG STRUCTURE; EX VIVO STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HISTOCHEMISTRY; IMAGE QUALITY; LEFT CORONARY ARTERY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; ANIMAL; EVALUATION; HEART; HEART INFARCTION; HEART MUSCLE; HEART SCINTISCANNING; IMAGE PROCESSING; PATHOLOGY; SCINTISCANNING; WISTAR RAT;

ANIMALS; FLUORINE RADIOISOTOPES; HEART; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PYRIDAZINES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR;

EID: 66449092434     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.108.815423     Document Type: Article

References (31)

1. Gibbons RJ, Valeti US, Araoz PA. The quantification of infarct size. J Am Coll Cardiol. 2004;44:1533-1542.
2. Schwaiger M, Melin J. Cardiological applications of nuclear medicine. Lancet. 1999;354:661-666.
3. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm-paradoxic or predictable? Circulation. 1993;88:296-306.
4. Miller TD, Christian TF, Hopfenspirger MR. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation. 1995;92:334-341.
5. Schomig A, Kastrati A, Dirschinger J. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction study investigators. N Engl J Med. 2000;343:385-391.
6. Kastrati A, Mehilli J, Dirschinger J; Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction (STOPAMI-2) study. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet. 2002;359:920-925.
7. Knuuti J, Bengel FM. Positron emission tomography and molecular imaging [Review]. Heart. 2008;94:360-367.
8. Yalamanchili P, Wexler E, Hayes M. Mechanism of uptake and retention of 18F BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol. 2007;14:782-788.
9. Huisman MC, Higuchi T, Reder S. Initial characterization of an 18FLabeled myocardial perfusion tracer. J Nucl Med. 2008;49:630-636.
10. Yu M, Guaraldi MT, Mistry M. BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol. 2007;14:789-798.
11. Stegger L, Hoffmeier AN, Schafers KP. Accurate noninvasive measurement of infarct size in mice with high-resolution PET. J Nucl Med. 2006;47:1837-1844.
12. Liu Z, Kastis GA, Stevenson GD. Quantitative analysis of acute myocardial infarct in rat hearts with ischemia-reperfusion using a highresolution stationary SPECT system. J Nucl Med. 2002;43:933-939.
13. Higuchi T, Nekolla ST, Jankaukas A. Characterization of normal and infarcted rat myocardium using a combination of small-animal PET and clinical MRI. J Nucl Med. 2007;48:288-294.
14. Thomas D, Bal H, Arkles J. Noninvasive assessment of myocardial viability in a small animal model: comparison of MRI, SPECT, and PET. Magn Reson Med. 2008;59:252-259.
15. Kudo T, Fukuchi K, Annala AJ. Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph. Circulation. 2002;106:118-123.
16. Ott I, Keller U, Knoedler M. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J. 2005;19:992-994.
17. Nekolla SG, Miethaner C, Nguyen N. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med. 1998;25:1313-1321.
18. Hoffman EJ, Phelps ME, Wisenberg G. Electrocardiographic gating in positron emission computed tomography. J Comput Assist Tomogr. 1979;3:733-739.
19. Hattori N, Bengel FM, Mehilli J. Global and regional functional measurements with gated FDG PET in comparison with left ventriculography. Eur J Nucl Med. 2001;28:221-229.
20. 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats. J Nucl Med. 2008;49:1715-1722.
21. Schwarz ER, Somoano Y, Hale SL. What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat? J Thromb Thrombolysis. 2000;10:181-187.
22. Hirai T, Nohara R, Hosokawa R. Evaluation of myocardial infarct size in rat heart by pinhole SPECT. J Nucl Cardiol. 2000;7:107-111.
23. Wu MC, Gao DW, Sievers RE. Pinhole single-photon emission computed tomography for myocardial perfusion imaging of mice. J Am Coll Cardiol. 2003;42:576-582.
24. Maskali F, Franken PR, Poussier S. Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study. J Nucl Med. 2006;47:337-344.
25. Acton PD, Thomas D, Zhou R. Quantitative imaging of myocardial infarct in rats with high resolution pinhole SPECT. Int J Cardiovasc Imaging. 2006;22:429-434.
26. 18F-fluoro-2-deoxy-D-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging. 2002;29:203-215.
27. Saeed M, Weber O, Lee R. Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media. J Am Coll Cardiol. 2006;48:1961-1968.
28. Oshinski JN, Yang Z, Jones JR. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation. 2001;104:2838-2842.
29. Yamashita K, Tamaki N, Yonekura Y. Quantitative analysis of regional wall motion by gated myocardial positron emission tomography: validation and comparison with left ventriculography. J Nucl Med. 1989;30:1775-1786.
30. Croteau E, Bénard F, Cadorette J. Quantitative gated PET for the assessment of left ventricular function in small animals. J Nucl Med. 2003;44:1655-1661.
31. Schäfers KP, Lang N, Stegger L. Gated listmode acquisition with the quad HIDAC animal PET to image mouse hearts. Z Med Phys. 2006;16:60-66.